Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ke Lv

Showing results (171-180 of 176) with videos related to

Pageof 18
Sort By:
You have reached the last page of results.This site can display upto 176 results.
Abdominal Radiology (New York)|June 17, 2021
Prospective assessment of diagnostic efficacy and safety of Sonazoid<sup>TM</sup> and SonoVue<sup>®</sup> ultrasound contrast agents in patients with focal liver lesionsKe Lv, Hongyan Zhai, Yuxin Jiang, et al.
Quantitative Imaging in Medicine and Surgery|June 7, 2023
Pancreatic ductal adenocarcinoma with synchronous and metachronous hepatic metastasis predicted by contrast-enhanced ultrasoundWan-Ying Jia, Yang Gui, Xue-Qi Chen, et al.
Quantitative Imaging in Medicine and Surgery|July 29, 2025
Ophthalmic changes are associated with visual cortex functional network reorganization after 90-day head-down tilt bed restLinkun Cai, Ke Lv, Haijun Niu, et al.
Nature Medicine|December 11, 2012
miR-214 targets ATF4 to inhibit bone formationXiaogang Wang, Baosheng Guo, Qi Li, et al.
Science Bulletin|June 19, 2026
AGR2-high cells drive a FOXM1-mediated pro-malignancy program in non-functional pancreatic neuroendocrine tumors (NF-PanNETs) and informatively predict patient outcomesJunya Peng, Rui Jiang, Jiajuan Tu, et al.
International Journal of Surgery (London, England)|September 10, 2025
Expert consensus regarding the clinical application of liver contrast-enhanced US with Sonazoid (Sonazoid CEUS)Jianhua Zhou, Lingling Li, Kun Yan, et al.
Pageof 18

Showing results (171-180 of 176) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 176 results.
Abdominal Radiology (New York)|June 17, 2021
Prospective assessment of diagnostic efficacy and safety of Sonazoid<sup>TM</sup> and SonoVue<sup>®</sup> ultrasound contrast agents in patients with focal liver lesionsKe Lv, Hongyan Zhai, Yuxin Jiang, et al.
Quantitative Imaging in Medicine and Surgery|June 7, 2023
Pancreatic ductal adenocarcinoma with synchronous and metachronous hepatic metastasis predicted by contrast-enhanced ultrasoundWan-Ying Jia, Yang Gui, Xue-Qi Chen, et al.
Quantitative Imaging in Medicine and Surgery|July 29, 2025
Ophthalmic changes are associated with visual cortex functional network reorganization after 90-day head-down tilt bed restLinkun Cai, Ke Lv, Haijun Niu, et al.
Nature Medicine|December 11, 2012
miR-214 targets ATF4 to inhibit bone formationXiaogang Wang, Baosheng Guo, Qi Li, et al.
Science Bulletin|June 19, 2026
AGR2-high cells drive a FOXM1-mediated pro-malignancy program in non-functional pancreatic neuroendocrine tumors (NF-PanNETs) and informatively predict patient outcomesJunya Peng, Rui Jiang, Jiajuan Tu, et al.
International Journal of Surgery (London, England)|September 10, 2025
Expert consensus regarding the clinical application of liver contrast-enhanced US with Sonazoid (Sonazoid CEUS)Jianhua Zhou, Lingling Li, Kun Yan, et al.
Pageof 18